This article demonstrates the operation and effect of in vivo confocal microscopy in the diagnosis and treatment of dry eye and investigates the application and outcomes of in vivo confocal microscopy to provide a basis for future research.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
This article demonstrates the operation and effect of in vivo confocal microscopy in the diagnosis and treatment of dry eye and investigates the application and outcomes of in vivo confocal microscopy to provide a basis for future research.
In vivo confocal microscopy (IVCM) has gained significant attention for its non-invasive nature and high resolution. It enables in vivo observation and objective quantification of numerous dry eye disease (DED)-related ocular surface structures, including the cornea, conjunctiva, eyelid margin, meibomian glands, and parasites such as Demodex, at the cellular level. This capability assists ophthalmologists in identifying specific etiologies and subtypes of DED, thereby facilitating precise diagnosis, targeted treatment, and prognostic evaluation. However, standardized protocols for IVCM operation and reporting remain lacking. Proficiency in both ophthalmic knowledge and technical operation is essential to effectively utilize this device and generate high-quality reports. This article details the procedural steps and nuances of IVCM examination for DED patients. This is the first JoVE step-by-step IVCM protocol for DED. It aims to serve as a reference for clinicians, helping them avoid operational inefficiencies and consistently obtain high-quality corneal and ocular surface images to guide clinical management.
Due to constraints in local medical resources or patient financial burdens, the clinical diagnosis of DED often focuses on only a basic aspect (e.g., observation under the slit lamp microscope, complaining of dryness and itching of the eyes) or even a single indicator (e.g., invasive tear film break-up time, lacrimal secretion test, or Demodex infestation). IVCM application is not widely available, let alone standardizing protocols for it. However, for ophthalmic institutions equipped with IVCM, the author recommends that first-time patients undergo a comprehensive microscopic examination to avoid omissions, including the cornea, conjunctiva, and palpebral margin. For equivocal DED cases or for detecting Demodex, IVCM is especially suitable for an explicit answer.
Dry eye disease (DED) is defined as a chronic ocular surface condition caused by abnormalities in the quality or quantity of tear fluid and decreased stability of the tear film. In the Dry Eye Workshop II (DEWS II), DED is classified into five types: aqueous-deficient dry eye (ADE), evaporative dry eye (EDE), mixed dry eye (MDE), predisposition to dry eye, and pre-clinical dry eye state1. Ralene et al. summarized the important clinical practice of IVCM in different types of dry eye, including the literature published from 2017 to 20222. Recent research has shown that inflammation plays a key role in the pathogenesis of DED3,4. Especially, the dendritic cells (DCs) density may be a good indicator of DED associated with a systemic immune-mediated process5.
The IVCM utilizes confocal laser tomography technology. It offers horizontal and vertical resolutions of 1 µm. Detailed technical specifications of the device are documented in the report by Jeremy et al6. During ocular surface examination, IVCM is first applied to the cornea7, followed by the conjunctiva and meibomian glands8. Demodex blepharitis has garnered increasing clinical attention in recent years9,10. IVCM provides clear images of the cornea, conjunctiva, and palpebral margin. These images allow clinicians to assess disease status and facilitate the imaging and quantification of inflammatory and immune cells.
In DED assessment, our focus includes: corneal epithelial cells (CEC); subepithelial nerve fibers (SNF); interepithelial and subepithelial inflammatory/immune cells; conjunctival goblet cells (CGCs); conjunctival inflammatory/immune cells; meibomian gland acini and orifices; Demodex folliculorum and Demodex brevis; and inflammatory cells within surrounding tissues. This emphasis stems from the pathophysiology: Meibomian gland dysfunction leads to reduced secretion or altered composition of the tear film's lipid layer, resulting in accelerated tear evaporation and ocular surface damage. Demodex infestation contributes to ocular itching and discomfort. CGCs secrete mucin, a critical tear film component; their depletion can cause mucin-deficient DED. Conversely, DED itself damages ocular surface structures, including CEC and SNF, and subsequently elevates inflammatory/immune cell density in corneal and conjunctival tissues. After obtaining the ideal pictures, we can effectively utilize the software's built-in quantitative tools to count the multitudinous cells mentioned (Figure 1). But for the morphological diversity of SNF, we need to rely on analytic software to help with the quantification11,12.
IVCM is indispensable for real-time assessment of corneal layers, nerve fibers, and inflammatory/immune cells in ocular surface tissues. For evaluating CGCs, impression cytology serves as an alternative method. This technique targets the fornix conjunctiva, where goblet cell density peaks, yielding values typically higher than IVCM measurements13,14. However, results are subject to staining variability and operator expertise, while the time-intensive protocol limits routine clinical implementation. Meibomian gland orifice obstruction is directly observable via slit-lamp microscopy, yet this method cannot detect Demodex brevis-induced blockages, which IVCM accurately identifies. For diagnosing Demodex infestation, eyelash epilation with light microscopy examination provides a low-cost method. While technically simple, this approach carries significant limitations: patient discomfort restricts multiple sampling, mites residing deep within eyelash follicles or meibomian gland orifices remain undetectable15. In contrast, IVCM enables comprehensive examination of multiple lid margin sites, including eyelash follicles and meibomian gland orifices, with minimal patient discomfort. This approach achieves substantially higher diagnostic positivity rates through real-time in vivo visualization of parasites within their microhabitats16,17.
Access restricted. Please log in or start a trial to view this content.
The examination procedure has been approved by the Ethics Committee of Hankou Aier Eye Hospital, and informed consent has been obtained from all patients.
NOTE: The inclusion criteria for patient selection include patients presenting with complaints of dry and itchy eyes, and individuals seeking routine eye examinations. The exclusion criteria for patient selection include patients with corneal perforation or impending corneal perforation, those allergic to topical ocular anesthetics, individuals too young (e.g., under 3 years old) or too old to cooperate, patients with narrow palpebral fissures unable to accommodate an eyelid speculum, pregnant women, and individuals unable to cooperate for other reasons. A brief workflow diagram can be found in Figure 2. And the detailed operation steps are as follows.
1. Pre-examination
2. During examination
3. Post-examination
Access restricted. Please log in or start a trial to view this content.
All IVCM microscopic images were acquired at a resolution of 384 pixels × 384 pixels, an observation field of 400 µm × 400 µm. When properly "zeroed", this examination will display only three possible outcomes in the image frame: i) No image at all (unsuccessful experiment): The central optical zone made no contact with the target tissue. ii) Only a partial image (Figure 7) or other abnormal situations (Figure 8) (unsuccessful experiment): The central optical zo...
Access restricted. Please log in or start a trial to view this content.
A PubMed literature search using the keywords "in vivo confocal microscopy" and "dry eye disease" (retrieved June 2025) yielded > 300 publications. Notably, annual publication rates have stabilized at approximately 40 papers per year since 2021. Broader applications of IVCM in ocular surface disorders have generated > 2,000 studies over the past two decades (2004-2024). Clinically, IVCM has revolutionized cellular-level assessment of ocular surface pathologies. This technology enables the...
Access restricted. Please log in or start a trial to view this content.
The authors declare no conflict of interest.
The authors thank Lina Jin at Hankou Aier Eye Hospital and Min Chen at Ophthalmology Department of Wuhan Asia Heart Hospital for assisting with some pictures, and all the participants and the staff members working for the operating procedure. This research was supported by a grant from Scientific Research Projects from Wuhan Municipal Health Commission(WX23A20).
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Absorbent cotton balls | JIAN QI, China | http://www.hnjianqi.com | For making alcohol balls, small |
| Alcohol-based gel | Li Kang, Shanghai, China | 31107904 | Hand antiseptic rinse free gel, 500ml |
| Carbomer Eye Drops | Vidisic, Germany | 8187195 | Sterile ophthalmic gel for coupling agent, 10g |
| Corneal contact cap(TomoCap) | Heidelberg, Germany | 18829 | Optical medium and contacting cornea asepticly |
| Eyelid speculum | Asicon, China | 6102A | For opening the eyes |
| Heidelberg Eye Explorer software | Heidelberg, Germany | Version 1.5.2.0 | The software that comes with the IVCM device |
| IVCM device | Heidelberg, Germany | HRT-?,08398 | The main equipment of the examination |
| Medical cotton swabs | Esound Med, China | www.e-soundmed.com | For cleaning the patients'eyes and assisting opening the eyes, 10cm |
| 75% Medicinal alcohol | HUICHANG, China | www.huichang888.cn | For making alcohol balls, 75%±5% 500ml |
| 0.4% Oxybuprocaine Hydrochloride Eye Drops | Santen, Japan | http://www.santen.co.jp | Ophthalmic topical anesthetic, 0.4% (0.5ml: 2mg) |
| Tobramycin Eye Drops | TOBREX, Belgium | 8453824 | Anti-inflammatory eye drops, 0.3% (5ml: 15mg) |
Access restricted. Please log in or start a trial to view this content.